Nebraska Couple's Reglan Claims Time-Barred, Judge Says

Law360, New York (August 22, 2016, 7:24 PM EDT) -- A Nebraska federal court on Friday tossed a product liability suit accusing Pfizer Inc., Wyeth LLC and Schwarz Pharma Inc. of hiding that the heartburn drug Reglan can cause a rare movement disorder if taken for a prolonged period, ruling the couple behind the suit waited more than a decade too long to file.

Ruling the couple’s allegations of fraud on the drugmakers’ parts were a stretch, U.S. District Judge Laurie Smith Camp said Cathy and Steve King offered no evidence showing why the state’s 10-year statute of repose began running any later than 1988, when Cathy King began taking the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!